Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Multiple Sclerosis
2		Additional conditions recognized in this trial
			Multiple Sclerosis, Relapsing-Remitting
			Sclerosis
3		More general conditions related to this trial
			Autoimmune Diseases
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
4		Interventions listed in this trial
			copolymer 1
5		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Immunologic Factors
			Immunosuppressive Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
6		Sponsors listed in this trial
			National Center for Research Resources (NCRR)
			University of Maryland